Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
BMC Infect Dis ; 16: 191, 2016 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-27138039

RESUMEN

BACKGROUND: Chronic Chagas disease presents different clinical manifestations ranging from asymptomatic (namely indeterminate) to severe cardiac and/or digestive. Previous results have shown that the immune response plays an important role, although no all mechanisms are understood. Immunoregulatory mechanisms such as apoptosis are important for the control of Chagas disease, possibly affecting the morbidity in chronic clinical forms. Apoptosis has been suggested to be an important mechanism of cellular response during T. cruzi infection. We aimed to further understand the putative role of apoptosis in Chagas disease and its relation to the clinical forms of the disease. METHODS: Apoptosis of lymphocytes, under antigenic stimuli (soluble T. cruzi antigens - TcAg) where compared to that of non-stimulated cells. Apoptosis was evaluated using the expression of annexin and caspase 3(+) by T cells and the percentage of cells positive evaluated by flow cytometry. In addition activation and T cell markers were used for the identification of TCD4(+) and TCD8(+) subpopulations. The presence of intracellular and plasma cytokines were also evaluated. Analysis of the activation status of the peripheral blood cells showed that patients with Chagas disease presented higher levels of activation determined by the expression of activation markers, after TcAg stimulation. PCR array were used to evaluate the contribution of this mechanism in specific cell populations from patients with different clinical forms of human Chagas disease. RESULTS: Our results showed a reduced proliferative response associated a high expression of T CD4(+)CD62L(-) cells in CARD patients when compared with IND group and NI individuals. We also observed that both groups of patients presented a significant increase of CD4(+) and CD8(+) T cell subsets in undergoing apoptosis after in vitro stimulation with T. cruzi antigens. In CARD patients, both CD4(+) and CD8(+) T cells expressing TNF-α were highly susceptible to undergo apoptosis after in vitro stimulation. Interestingly, the in vitro TcAg stimulation increased considerably the expression of cell death TNF/TNFR superfamily and Caspase family receptors genes in CARD patients. CONCLUSIONS: Taken together, our results suggest that apoptosis may be an important mechanism for the control of morbidity in T. cruzi infection by modulating the expression of apoptosis genes, the cytokine environment and/or killing of effector cells.


Asunto(s)
Enfermedad de Chagas/inmunología , Enfermedad de Chagas/patología , Trypanosoma cruzi/patogenicidad , Adulto , Anciano , Antígenos de Protozoos/farmacología , Apoptosis/efectos de los fármacos , Apoptosis/inmunología , Linfocitos T CD8-positivos/inmunología , Cardiomiopatías/parasitología , Proliferación Celular , Enfermedad de Chagas/complicaciones , Citocinas/sangre , Femenino , Citometría de Flujo , Humanos , Selectina L/metabolismo , Masculino , Persona de Mediana Edad , Subgrupos de Linfocitos T , Trypanosoma cruzi/inmunología , Factor de Necrosis Tumoral alfa/sangre
2.
Infect Immun ; 81(10): 3600-8, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23856618

RESUMEN

Dilated chronic cardiomyopathy (DCC) from Chagas disease is associated with myocardial remodeling and interstitial fibrosis, resulting in extracellular matrix (ECM) changes. In this study, we characterized for the first time the serum matrix metalloproteinase 2 (MMP-2) and MMP-9 levels, as well as their main cell sources in peripheral blood mononuclear cells from patients presenting with the indeterminate (IND) or cardiac (CARD) clinical form of Chagas disease. Our results showed that serum levels of MMP-9 are associated with the severity of Chagas disease. The analysis of MMP production by T lymphocytes showed that CD8(+) T cells are the main mononuclear leukocyte source of both MMP-2 and MMP-9 molecules. Using a new 3-dimensional model of fibrosis, we observed that sera from patients with Chagas disease induced an increase in the extracellular matrix components in cardiac spheroids. Furthermore, MMP-2 and MMP-9 showed different correlations with matrix proteins and inflammatory cytokines in patients with Chagas disease. Our results suggest that MMP-2 and MMP-9 show distinct activities in Chagas disease pathogenesis. While MMP-9 seems to be involved in the inflammation and cardiac remodeling of Chagas disease, MMP-2 does not correlate with inflammatory molecules.


Asunto(s)
Cardiomiopatía Chagásica/enzimología , Regulación Enzimológica de la Expresión Génica/inmunología , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Adulto , Anciano , Biomarcadores/sangre , Cardiomiopatía Chagásica/metabolismo , Humanos , Metaloproteinasa 2 de la Matriz/sangre , Metaloproteinasa 2 de la Matriz/genética , Metaloproteinasa 9 de la Matriz/sangre , Metaloproteinasa 9 de la Matriz/genética , Persona de Mediana Edad
3.
Clin Chim Acta ; 490: 107-112, 2019 Mar.
Artículo en Francés | MEDLINE | ID: mdl-30543791

RESUMEN

OBJECTIVE: This study has investigated whether high levels of Reticulocytes-C4d (R-C4d) and Platelets-C4d (P-C4d) reflecting recent activity in SLE patients are correlated with changes in natural anticoagulation components, coagulation activation and endothelial injury markers. METHODS: This study included three groups: 1) healthy women (control, n = 30); 2) women with low activity of the disease (SLEDAI 2 K ≤ 4, n = 30); 3) women with active disease (moderate or high activity) (SLEDAI 2 K > 4, n = 30). Median fluorescence intensity (MFI) of R-C4d and P-C4d were determined by flow cytometry using double labeling with specific monoclonal antibodies. Endothelial injury and hypercoagulability were evaluated by measuring Thrombomodulin and D-dimer levels. RESULTS: Higher MFI index of R-C4d were related to the recent activity of SLE, and higher expression of P-C4d indicated an elevated risk of thrombotic complications. Increased levels of soluble thrombomodulin and D-dimer were observed in patients with active SLE. CONCLUSION: R-C4d is helpful to monitor early disease activity and PC4-d may be an important tool to detect a prothrombotic phenotype in SLE. Elevated levels of D-dimer and thrombomodulin add value to P-C4d data and corroborate a hypercoagulable profile in women with SLE, contributing to an increased prothrombotic risk associated with inflammation.


Asunto(s)
Coagulación Sanguínea , Plaquetas/metabolismo , Lupus Eritematoso Sistémico/sangre , Lupus Eritematoso Sistémico/fisiopatología , Fragmentos de Péptidos/sangre , Reticulocitos/metabolismo , Adulto , Anciano , Estudios de Casos y Controles , Complemento C4b , Femenino , Humanos , Persona de Mediana Edad , Adulto Joven
4.
PLoS One ; 9(3): e87082, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24603474

RESUMEN

The expression of immune response appears to be associated with morbidity in Chagas disease. However, the studies in this field have usually employed small samples of patients and statistical analyses that do not consider the wide dispersion of cytokine production observed in these patients. The aim of this study was to evaluate the plasma cytokine levels in well-defined clinical polar groups of chagasic patients divided into categories that better reflect the wide cytokine profile and its relationship with morbidity. Patients infected with Trypanosoma cruzi (T. cruzi) were grouped as indeterminate (IND) and cardiac (CARD) forms ranging from 23 to 69 years of age (mean of 45.6±11.25). The IND group included 82 individuals, ranging from 24 to 66 years of age (mean of 39.6±10.3). The CARD group included 94 patients ranging from 23 to 69 years of age (mean of 48±12.52) presenting dilated cardiomyopathy. None of the patients have undergone chemotherapeutic treatment, nor had been previously treated for T. cruzi infection. Healthy non-chagasic individuals, ranging from 29 to 55 years of age (mean of 42.6±8.8) were included as a control group (NI). IND patients have a higher intensity of interleukin 10 (IL-10) expression when compared with individuals in the other groups. By contrast, inflammatory cytokine expression, such as interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), and interleukin 1 beta (IL-1ß), proved to be the highest in the CARD group. Correlation analysis showed that higher IL-10 expression was associated with better cardiac function, as determined by left ventricular ejection fraction and left ventricular diastolic diameter values. Altogether, these findings reinforce the concept that a fine balance between regulatory and inflammatory cytokines represents a key element in the establishment of distinct forms of chronic Chagas disease.


Asunto(s)
Cardiomiopatía Chagásica/inmunología , Enfermedad de Chagas/inmunología , Citocinas/inmunología , Trypanosoma cruzi/inmunología , Adulto , Cardiomiopatía Chagásica/sangre , Cardiomiopatía Chagásica/epidemiología , Enfermedad de Chagas/sangre , Enfermedad de Chagas/epidemiología , Estudios Transversales , Citocinas/sangre , Citometría de Flujo , Humanos , Mediadores de Inflamación/sangre , Mediadores de Inflamación/inmunología , Interferón gamma/sangre , Interferón gamma/inmunología , Interleucina-10/sangre , Interleucina-10/inmunología , Interleucina-1beta/sangre , Interleucina-1beta/inmunología , Interleucina-6/sangre , Interleucina-6/inmunología , Persona de Mediana Edad , Morbilidad , Adulto Joven
6.
Rev. bras. cardiol. (Impr.) ; 26(3): 221-230, mai.-jun. 2013. ilus
Artículo en Portugués | LILACS | ID: lil-704391

RESUMEN

A aterotrombose é uma doença do sistema circulatório cujas manifestações clínicas mais significativas (infarto do miocárdio e acidente vascular encefálico) representam atualmente as principais causas de mortalidade, com expectativa de que sua incidência aumente nos próximos anos. O uso clínico de antiagregantes plaquetários encontra-se firmemente consolidado como terapia de escolha na prevenção primária e secundária de eventos clínicos relacionados à aterotrombose. A presente revisão tem como objetivo realizar uma descrição dos aspectos gerais da aterotrombose e dos principais fármacos antiagregantes plaquetários, com uma descrição breve de seus aspectos farmacodinâmicos e farmacocinéticos.


Atherothrombosis is a circulatory system disease whose most significant clinical manifestations (myocardial infarction and stroke) are today the leading causes of death worldwide, expected to increase over the coming years. The clinical use of antiplatelet agents is firmly established as the therapy of choice in primary and secondary prevention of clinical events related to atherothrombosis. This review offers a description of the general aspects of atherothrombosis and the main antiplatelet drugs,with a brief outline of their pharmacodynamic and pharmacokinetic aspects.


Asunto(s)
Enfermedades Cardiovasculares/complicaciones , Enfermedades Cardiovasculares/mortalidad , Factores de Riesgo , Inhibidores de Agregación Plaquetaria/administración & dosificación , Aspirina/administración & dosificación , Aspirina/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA